Mitotic defects in XRCC3 variants T241M and D213N and their relation to cancer susceptibility

Human Molecular Genetics

Volumn 15, Issue 7, 2006, Pages 1217-1224

  Lindh, Anna Renglin ^a   Rafii, Saeed ^b   Schultz, Niklas ^a   Cox, Angela ^b   Helleday, Thomas ^a,b  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; ASPARTIC ACID; GENE PRODUCT; METHIONINE; PROTEIN XRCC3; THREONINE; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER SUSCEPTIBILITY; CELL COUNT; CELL NUCLEUS; CENTROSOME; CONTROLLED STUDY; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN VARIANT;

ALLELES; ANIMALS; APOPTOSIS; CELL LINE; CELLS, CULTURED; CENTROSOME; CHO CELLS; CRICETINAE; DISEASE SUSCEPTIBILITY; DNA-BINDING PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MITOSIS; NEOPLASMS; VARIATION (GENETICS);

ANIMALIA;

EID: 33645130127     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddl037     Document Type: Article

References (36)

1. Venkitaraman, A.R. (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell, 108, 171-182.
2. Tutt, A., Bertwistle, D., Valentine, J., Gabriel, A., Swift, S., Ross, G., Griffin, C., Thacker, J. and Ashworth, A. (2001) Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences. EMBO J., 20, 4704-4716.
3. Tutt, A., Gabriel, A., Bertwistle, D., Connor, F., Paterson, H., Peacock, J., Ross, G. and Ashworth, A. (1999) Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification. Curr. Biol., 9, 1107-1110.
4. Xu, X., Weaver, Z., Linke, S.P., Li, C., Gotay, J., Wang, X.W., Harris, C.C., Ried, T. and Deng, C.X. (1999) Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol. Cell, 3, 389-395.
5. Hsu, L.C. and White, R.L. (1998) BRCA1 is associated with the centrosome during mitosis. Proc. Natl Acad. Sci. USA, 95, 12983-12988.
6. Hsu, L.C., Doan, T.P. and White, R.L. (2001) Identification of a gamma-tubulin-binding domain in BRCA1. Cancer Res., 61, 7713-7718.
7. Daniels, M.J., Wang, Y., Lee, M. and Venkitaraman, A.R. (2004) Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2. Science, 306, 876-879.
8. Pierce, A.J., Johnson, R.D., Thompson, L.H. and Jasin, M. (1999) XRCC3 promotes homology-directed repair of DNA damage in mammalian cells. Genes Dev., 13, 2633-2638.
9. Griffin, C.S., Simpson, P.J., Wilson, C.R. and Thacker, J. (2000) Mammalian recombination-repair genes XRCC2 and XRCC3 promote correct chromosome segregation. Nat. Cell Biol., 2, 757-761.
10. Rafii, S., Lindblom, A., Reed, M., Meuth, M. and Cox, A. (2003) A naturally occurring mutation in an ATP-binding domain of the recombination repair gene XRCC3 ablates its function without causing cancer susceptibility. Hum. Mol. Genet., 12, 915-923.
11. Kuschel, B., Auranen, A., McBride, S., Novik, K.L., Antoniou, A., Lipscombe, J.M., Day, N.E., Easton, D.F., Ponder, B.A., Pharoah, P.D. et al. (2002) Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum. Mol. Genet., 11, 1399-1407.
12. Jacobsen, N.R., Raaschou-Nielsen, O., Nexo, B., Wallin, H., Overvad, K., Tjonneland, A. and Vogel, U. (2004) XRCC3 polymorphisms and risk of lung cancer. Cancer Lett., 213, 67-72.
13. Seedhouse, C., Faulkner, R., Ashraf, N., Das-Gupta, E. and Russell, N. (2004) Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia. Clin. Cancer Res., 10, 2675-2680.
14. Benhamou, S., Tuimala, J., Bouchardy, C., Dayer, P., Sarasin, A. and Hirvonen, A. (2004) DNA repair gene XRCC2 and XRCC3 polymorphisms and susceptibility to cancers of the upper aerodigestive tract. Int. J. Cancer, 112, 901-904.
15. Jacobsen, N.R., Nexo, B.A., Olsen, A., Overvad, K., Wallin, H., Tjonneland, A. and Vogel, U. (2003) No association between the DNA repair gene XRCC3 T241M polymorphism and risk of skin cancer and breast cancer. Cancer Epidemiol. Biomarkers Prev., 12, 584-585.
16. Figueiredo, J.C., Knight, J.A., Briollais, L., Andrulis, I.L. and Ozcelik, H. (2004) Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry. Cancer Epidemiol. Biomarkers Prev., 13, 583-591.
17. Thacker, J. (2005) The RAD51 gene family, genetic instability and cancer. Cancer Lett., 219, 125-135.
18. Araujo, F.D., Pierce, A.J., Stark, J.M. and Jasin, M. (2002) Variant XRCC3 implicated in cancer is functional in homology-directed repair of double-strand breaks. Oncogene, 21, 4176-4180.
19. Lengauer, C., Kinzler, K.W. and Vogelstein, B. (1998) Genetic instabilities in human cancers. Nature, 396, 643-649.
20. Tebbs, R.S., Zhao, Y., Tucker, J.D., Scheerer, J.B., Siciliano, M.J., Hwang, M., Liu, N., Legerski, R.J. and Thompson, L.H. (1995) Correction of chromosomal instability and sensitivity to diverse mutagens by a cloned cDNA of the XRCC3 DNA repair gene. Proc. Natl Acad. Sci. USA, 92, 6354-6358.
21. Fuller, L.F. and Painter, R.B. (1988) A Chinese hamster ovary cell line hypersensitive to ionizing radiation and deficient in repair replication. Mutat. Res., 193, 109-121.
22. Schultz, N. and Onfelt, A. (1994) Video time-lapse study of mitosis in binucleate V79 cells: Chromosome segregation and cleavage. Mutagenesis, 9, 117-123.
23. Hinz, J.M., Helleday, T. and Meuth, M. (2003) Reduced apoptotic response to camptothecin in CHO cells deficient in XRCC3. Carcinogenesis, 24, 249-253.
24. Martin, S.J., Reutelingsperger, C.P., McGahon, A.J., Rader, J.A., van Schie, R.C., LaFace, D.M. and Green, D.R. (1995) Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med., 182, 1545-1556.
25. Yamada, N.A., Hinz, J.M., Kopf, V.L., Segalle, K.D. and Thompson, L.H. (2004) XRCC3 ATPase activity is required for normal XRCC3-Rad51C complex dynamics and homologous recombination. J. Biol. Chem., 279, 23250-23254.
26. Dodson, H., Bourke, E., Jeffers, L.J., Vagnarelli, P., Sonoda, E., Takeda, S., Earnshaw, W.C., Merdes, A. and Morrison, C. (2004) Centrosome amplification induced by DNA damage occurs during a prolonged G2 phase and involves ATM. EMBO J., 23, 3864-3873.
27. Yoshihara, T., Ishida, M., Kinomura, A., Katsura, M., Tsuruga, T., Tashiro, S., Asahara, T. and Miyagawa, K. (2004) XRCC3 deficiency results in a defect in recombination and increased endoreduplication in human cells. EMBO J., 23, 670-680.
28. Hut, H.M., Lemstra, W., Blaauw, E.H., Van Cappellen, G.W., Kampinga, H.H. and Sibon, O.C. (2003) Centrosomes split in the presence of impaired DNA integrity during mitosis. Mol. Biol. Cell, 14, 1993-2004.
29. Meraldi, P. and Nigg, E.A. (2002) The centrosome cycle. FEBS Lett., 521, 9-13.
30. Vogel, C., Kienitz, A., Hofmann, I., Muller, R. and Bastians, H. (2004) Crosstalk of the mitotic spindle assembly checkpoint with p53 to prevent polyploidy. Oncogene, 23, 6845-6853.
31. Mohindra, A., Hays, L.E., Phillips, E.N., Preston, B.D., Helleday, T. and Meuth, M. (2002) Defects in homologous recombination repair in mismatch-repair-deficient tumour cell lines. Hum. Mol. Genet., 11, 2189-2200.
32. Giannini, G., Ristori, E., Cerignoli, F., Rinaldi, C., Zani, M., Viel, A., Ottini, L., Crescenzi, M., Martinotti, S., Bignami, M. et al. (2002) Human MRE11 is inactivated in mismatch repair-deficient cancers. EMBO Rep., 3, 248-254.
33. Segurado, M., Gomez, M. and Antequera, F. (2002) Increased recombination intermediates and homologous integration hot spots at DNA replication origins. Mol. Cell, 10, 907-916.
34. Ludwig, T., Chapman, D.L., Papaioannou, V.E. and Efstratiadis, A. (1997) Targeted mutations of breast cancer susceptibility gene homologs in mice: Lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev., 11, 1226-1241.
35. Connor, F., Bertwistle, D., Mee, P.J., Ross, G.M., Swift, S., Grigorieva, E., Tybulewicz, V.L. and Ashworth, A. (1997) Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Nat. Genet., 17, 423-430.
36. Kinzler, K.W. and Vogelstein, B. (1997) Cancer-susceptibility genes. Gatekeepers and caretakers. Nature, 386, 761-763.